Orchestra BioMed Holdings, Inc. Increase (Decrease) in Accounts Payable
Orchestra BioMed Holdings, Inc. (OBIO) reported Increase (Decrease) in Accounts Payable of $375.54 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-01-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2023-01-25
- Orchestra BioMed Holdings, Inc. increase (decrease) in accounts payable for the quarter ending 2022-12-31 was $95.37K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in accounts payable for the quarter ending 2022-09-30 was $110.90K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in accounts payable for the quarter ending 2022-06-30 was $67.05K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in accounts payable for the quarter ending 2022-03-31 was $102.22K, a 392.62% increase year-over-year.
- Orchestra BioMed Holdings, Inc. increase (decrease) in accounts payable for fiscal 2022 was $375.54K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in accounts payable for fiscal 2021 was -$12.42K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 4 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 7 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|---|
| 2022-12-31 | $95.37K derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-25 | $206.27K derived: sum of 2 quarters · filed 2023-01-25 | $273.32K derived: sum of 3 quarters · filed 2023-01-25 | $375.54K 10-K · filed 2023-01-25 | ||
| 2022-09-30 | $110.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $177.95K derived: sum of 2 quarters · filed 2022-11-14 | $280.17K 10-Q · filed 2022-11-14 | $279.91K derived: sum of 4 quarters · filed 2023-01-25 | ||
| 2022-06-30 | $67.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $169.27K 10-Q · filed 2022-08-15 | $169.00K derived: sum of 3 quarters · filed 2023-01-25 | $151.32K derived: sum of 4 quarters · filed 2023-01-25 | ||
| 2022-03-31 | $102.22K 10-Q · filed 2022-05-13 | $101.95K derived: sum of 2 quarters · filed 2023-01-25 | $84.27K derived: sum of 3 quarters · filed 2023-01-25 | $69.05K derived: sum of 4 quarters · filed 2023-01-25 | ||
| 2021-12-31 | -$267.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-25 | -$17.95K derived: sum of 2 quarters · filed 2023-01-25 | -$33.17K derived: sum of 3 quarters · filed 2023-01-25 | -$12.42K 10-K · filed 2023-01-25 | ||
| 2021-09-30 | -$17.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$32.91K derived: sum of 2 quarters · filed 2022-11-14 | -$12.15K 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | -$15.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $5.53K 10-Q · filed 2022-08-15 | ||||
| 2021-03-31 | $20.75K 10-Q · filed 2022-05-13 | |||||
| 2020-12-31 | $13.81K 10-K/A · filed 2022-03-31 | |||||
| 2020-09-30 | $1.45K 10-Q/A · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |